SARS‐CoV‐2 targets neurons of 3D human brain organoids
Open accessPublished version of a preprint
The DOI matches its Crossref record; 62 of the 63 references it cites were found in a registry or an index, and 1 are not checked yet.
Abstract
COVID-19 pandemic caused by SARS-CoV-2 infection is a public health emergency. COVID-19 typically exhibits respiratory illness. Unexpectedly, emerging clinical reports indicate that neurological symptoms continue to rise, suggesting detrimental effects of SARS-CoV-2 on the central nervous system (CNS). Here, we show that a Düsseldorf isolate of SARS-CoV-2 enters 3D human brain organoids within 2 days of exposure. We identified that SARS-CoV-2 preferably targets neurons of brain organoids. Imaging neurons of organoids reveal that SARS-CoV-2 exposure is associated with altered distribution of Tau from axons to soma, hyperphosphorylation, and apparent neuronal death. Our studies, therefore, provide initial insights into the potential neurotoxic effect of SARS-CoV-2 and emphasize that brain organoids could model CNS pathologies of COVID-19.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Notably, organoids can be cultivated over months and probably even years, thus enabling the investigation of tissue maturation in a disease context as shown for SARS-CoV-2 infections in brain organoids87”
From Human disease models in drug development (2023) · cites this paper as [87]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“SARS-CoV-2 tropism for neurons87 and cortical astrocytes88 or its preference for mature cell types and distinct neurotoxic effects were demonstrated in brain organoids.”
From Human disease models in drug development (2023) · cites this paper as [87]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., Schiergens, T. S., Herrler, G., Wu, N.-H., Nitsche, A., et al. (2020) · Cell · doi:10.1016/j.cell.2020.02.052 · Cited by 20,286
Yang, X., Yu, Y., Xu, J., Shu, H., Xia, J., Liu, H., Wu, Y., Zhang, L., Yu, Z., Fang, M., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30079-5 · Cited by 10,066
Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR
Corman, V. M., Landt, O., Kaiser, M., Molenkamp, R., Meijer, A., Chu, D. K., Bleicker, T., Brünink, S., Schneider, J., Schmidt, M. L., et al. (2020) · Eurosurveillance · doi:10.2807/1560-7917.es.2020.25.3.2000045 · Cited by 7,344
Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus
Li, W., Moore, M. J., Vasilieva, N., Sui, J., Wong, S. K., Berne, M. A., Somasundaran, M., Sullivan, J. L., Luzuriaga, K., Greenough, T. C., et al. (2003) · Nature · doi:10.1038/nature02145 · Cited by 5,923 · cited 7×
“ACE-2 is an entry receptor for SARS-CoV and efficient replication of SARS-CoV (SARS outbreak in the year 2003) and also depends on the expression level of ACE-2 (Li et al , 2003; Hoffmann et al , 2020).”
InfluentialCerebral organoids model human brain development and microcephaly
Lancaster, M. A., Renner, M., Martin, C.-A., Wenzel, D., Bicknell, L. S., Hurles, M. E., Homfray, T., Penninger, J. M., Jackson, A. P., & Knoblich, J. A. (2013) · Nature · doi:10.1038/nature12517 · Cited by 5,372 · cited 2×
“We adapted previously described protocol to differentiate iPSCs into brain organoids described earlier (Lancaster et al , 2013; Gabriel et al , 2016).”
Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study
Chen, T., Wu, D., Chen, H., Yan, W., Yang, D., Chen, G., Ma, K., Xu, D., Yu, H., Wang, H., et al. (2020) · BMJ · doi:10.1136/bmj.m1091 · Cited by 3,903 · cited 1×
“However, emerging case reports showed that patients infected with SARS-CoV-2 suffered a sudden and complete loss of the olfactory function, stroke, and other severe neurological symptoms (Chen et al , 2020; Helms et al , 2020; Poyiadji et al , 2020; Sedaghat & Karimi, 2020; Virani et al , 2020).”
Organogenesis in a dish: Modeling development and disease using organoid technologies
Lancaster, M. A., & Knoblich, J. A. (2014) · Science · doi:10.1126/science.1247125 · Cited by 2,931 · cited 1×
“Cortical neurons are positioned basally to the VZ, forming a cortical plate ) (Lancaster & Knoblich, 2014; Giandomenico & Lancaster, 2017; Gopalakrishnan, 2019).”
Neurologic features in severe SARS-CoV-2 infection
Helms, J., Kremer, S., Merdji, H., Clere-Jehl, R., Schenck, M., Kummerlen, C., Collange, O., Boulay, C., Fafi-Kremer, S., Ohana, M., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2008597 · Cited by 2,674
Tau in physiology and pathology
Wang, Y., & Mandelkow, E. (2016) · Nature Reviews Neuroscience · doi:10.1038/nrn.2015.1 · Cited by 2,251
Baig, A. M., Khaleeq, A., Ali, U., & Syeda, H. (2020) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.0c00122 · Cited by 2,207
Research works printed but not linked: 1
- Flint SJ, Racaniello VR, Rall GF, Skalka AM, Enquist LW (2015) Principles of virology. Washington, DC: ASM Press
Cited by
Items 101–200 of 524
Opportunities and challenges of glioma organoids
Xu, X., Li, L., Luo, L., Shu, L., Si, X., Chen, Z., Xia, W., Huang, J., Liu, Y., Shao, A., et al. (2021) · Cell Communication and Signaling · doi:10.1186/s12964-021-00777-0 · Cited by 56
Human Organoids and Organs‐on‐Chips for Addressing COVID‐19 Challenges
Wang, Y., Wang, P., & Qin, J. (2022) · Advanced Science · doi:10.1002/advs.202105187 · Cited by 51
Tropism of SARS-CoV-2 for Developing Human Cortical AstrocytesPreprint
Andrews, M. G., Mukhtar, T., Eze, U. C., Simoneau, C. R., Perez, Y., Mostajo-Radji, M. A., Wang, S., Velmeshev, D., Salma, J., Kumar, G. R., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.01.17.427024 · Cited by 53
“However the results regarding susceptibility of neurons of different brain regional identities have been mixed across studies and the capacity to infect other neural cell types, including glia, has not been extensively explored (7, 8, 24).”
ResultKnyazev, E. N., Nersisyan, S. A., & Tonevitsky, A. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.636966 · Cited by 47
Constant, O., Barthelemy, J., Bolloré, K., Tuaillon, É., Gosselet, F., Chable-Bessia, C., Mérida, P., Muriaux, D. M., de Perre, P. V., Salinas, S., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.697329 · Cited by 47
Brain organoids are new tool for drug screening of neurological diseases
Zhou, J.-Q., Zeng, L., Li, C.-T., He, D.-H., Zhao, H.-D., Xu, Y., Jin, Z.-T., & Gao, C. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.367983 · Cited by 54
“Table 1 summarizes the phenotypic features of the brain organoids (Zhu et al., 2017; Jacob et al., 2020; Marin Navarro et al., 2020; Ramani et al., 2020; James et al., 2022; Paulsen et al., 2022) or region-specific organoids (Gonzalez et al., 2018; Xu et al., 2019; Zhang et al., 2020; Kang et al.,…”
BackgroundInfluentialKong, D., Park, K. H., Kim, D., Kim, N. G., Lee, S., Shin, N., Kook, M. G., Kim, Y. B., & Kang, K. (2023) · Cell Death Discovery · doi:10.1038/s41420-022-01288-8 · Cited by 55
“Therefore, iPSC-derived brain organoids have been employed as an alternative model to investigate SARS-CoV-2 neurotropism [19, 20, 24, 26, 30].”
MethodBrain Disease Network Analysis to Elucidate the Neurological Manifestations of COVID-19
Prasad, K., Alomar, S. Y., Alqahtani, S. A. M., Malik, M. Z., & Kumar, V. (2021) · Molecular Neurobiology · doi:10.1007/s12035-020-02266-w · Cited by 49
Optimization of cerebral organoids: a more qualified model for Alzheimer’s disease research
Bi, F.-C., Yang, X.-H., Cheng, X.-Y., Deng, W.-B., Guo, X.-L., Yang, H., Wang, Y., Li, J., & Yao, Y. (2021) · Translational Neurodegeneration · doi:10.1186/s40035-021-00252-3 · Cited by 50
“[110] have reported that the preferential target of SARS-CoV2 is the cortical plate rather than the neural stem cells.”
BackgroundRamani, A., Pasquini, G., Gerkau, N. J., Jadhav, V., Vinchure, O. S., Altinisik, N., Windoffer, H., Muller, S. M., Rothenaigner, I., Lin, S., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-55226-6 · Cited by 60
Self-citationAdvances in 3D Organoids and Organ‐on‐a‐Chip Systems for Biomedical Research
Sakthivel, V., Dharshan, S. S., Namasivayam, S. K. R., & Arockiaraj, J. (2026) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbma.70028 · Cited by 56
3D biomaterial models of human brain disease
Kajtez, J., Nilsson, F., Fiorenzano, A., Parmar, M., & Emnéus, J. (2021) · Neurochemistry International · doi:10.1016/j.neuint.2021.105043 · Cited by 46
Engineering in vitro immune-competent tissue models for testing and evaluation of therapeutics
Hammel, J. H., Zatorski, J. M., Cook, S. R., Pompano, R. R., & Munson, J. M. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114111 · Cited by 44
Organoid and microfluidics-based platforms for drug screening in COVID-19
Ramezankhani, R., Solhi, R., Chai, Y. C., Vosough, M., & Verfaillie, C. M. (2021) · Drug Discovery Today · doi:10.1016/j.drudis.2021.12.014 · Cited by 47
Emerging Neurological and Psychobiological Aspects of COVID-19 Infection
Tancheva, L. P., Petralia, M. C., Miteva, S., Dragomanova, S., Solak, A., Kalfin, R. E., Lazarova, M. I., Yarkov, D., Ciurleo, R., Cavalli, E., et al. (2020) · Brain Sciences · doi:10.3390/brainsci10110852 · Cited by 44
The effect of influenza vaccination on trained immunity: impact on COVID-19Preprint
Debisarun, P. A., Struycken, P., Domínguez‐Andrés, J., Moorlag, S. J. C. F. M., Taks, E., Gössling, K. L., Ostermann, P. N., Müller, L., Schaal, H., ten Oever, J., et al. (2020) · medRxiv · doi:10.1101/2020.10.14.20212498 · Cited by 51
Self-citationSansone, D., Tassinari, A., Valentinotti, R., Kontogiannis, D., Ronchese, F., Centonze, S., Maggiore, A., Cegolon, L., & Filon, F. L. (2022) · Life · doi:10.3390/life13010097 · Cited by 44
Parihar, A., Pandita, V., & Khan, R. (2022) · Biotechnology and Bioengineering · doi:10.1002/bit.28166 · Cited by 41
iPSC-derived three-dimensional brain organoid models and neurotropic viral infections
Swingler, M., Donadoni, M., Bellizzi, A., Çakır, S., & Sariyer, I. K. (2023) · Journal of NeuroVirology · doi:10.1007/s13365-023-01133-3 · Cited by 45
A Perspective on Organoids for Virology Research
Sridhar, A., Simmini, S., Ribeiro, C. M. S., Tapparel, C., Evers, M. M., Pajkrt, D., & Wolthers, K. C. (2020) · Viruses · doi:10.3390/v12111341 · Cited by 41
“also showed infection of brain organoids through neurons, resulting in neuronal death [40].”
Backgroundde Andrade, E. G., Šimončičová, E., Carrier, M., Vecchiarelli, H. A., Robert, M.-È., & Tremblay, M. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.647378 · Cited by 40
“On one hand, human neural organoids seem to be limited in their ability to support SARS-CoV-2 replication (Pellegrini et al., 2020; Ramani et al., 2020).”
BackgroundVersace, V., Ortelli, P., Dezi, S., Ferrazzoli, D., Alibardi, A., Bonini, I., Engl, M., Maestri, R., Assogna, M., Ajello, V., et al. (2022) · Clinical Neurophysiology · doi:10.1016/j.clinph.2022.10.017 · Cited by 44
“If SARS-CoV-2 enters the brain it has the potential to access GABAergic neurons, leading to functional impairment until apoptosis and causing excitatoryinhibitory imbalance (Ramani et al., 2020).”
BackgroundVilladiego, J., García‐Arriaza, J., Ramírez‐Lorca, R., García‐Swinburn, R., Cabello-Rivera, D., Rosales‐Nieves, A. E., Álvarez-Vergara, M. I., Cala-Fernández, F., García‐Roldán, E., López-Ogáyar, J. L., et al. (2023) · Nature Neuroscience · doi:10.1038/s41593-022-01242-y · Cited by 46
Experimental Models for the Study of Central Nervous System Infection by SARS-CoV-2
Sanclemente-Alamán, I., Moreno‐Jiménez, L., Benito‐Martín, M. S., Canales-Aguirre, A. A., Matías‐Guiu, J. A., Matías‐Guiu, J., & Gómez‐Pinedo, U. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.02163 · Cited by 41
Bauer, L., Lendemeijer, B., Leijten, L. M. E., Embregts, C. W. E., Rockx, B., Kushner, S. A., de Vrij, F. M. S., & van Riel, D. A. J. (2021) · mSphere · doi:10.1128/msphere.00270-21 · Cited by 35
“hiPSC-derived brain organoids (22) and BrainSpheres (19), without efficient SARS-CoV2 replication.”
SARS-CoV-2-Mediated Neuropathogenesis, Deterioration of Hippocampal Neurogenesis and Dementia
Radhakrishnan, R. K., & Kandasamy, M. (2022) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/15333175221078418 · Cited by 40
Rothan, H. A., Kumari, P., Stone, S., Natekar, J. P., Arora, K., Auroni, T. T., & Kumar, M. (2022) · Pathogens · doi:10.3390/pathogens11020257 · Cited by 37
Neurological sequela and disruption of neuron-glia homeostasis in SARS-CoV-2 infection
Savelieff, M. G., Feldman, E. L., & Stino, A. M. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105715 · Cited by 42
“A German study concluded that a Düsseldorf isolate of SARS-CoV-2 preferentially targets neurons versus neuronal progenitor in human derived brain organoids (Ramani et al., 2020).”
Ng, J., Sun, A. X., Je, H. S., & Tan, E. (2021) · The Neuroscientist · doi:10.1177/10738584211015136 · Cited by 37
Human Brain Organoids as an In Vitro Model System of Viral Infectious Diseases
Su, X., Yue, P., Kong, J., Xu, X., Zhang, Y. L., Cao, W., Fan, Y., Liu, M., Chen, J., Liu, A., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2021.792316 · Cited by 43
“org 5 the abundance ofACE2 increasing over time, but it is less expressed in neurons and other cell types (38, 40, 43).”
BackgroundInfluentialSARS-CoV-2 and neurodegenerative diseases: what we know and what we don’t
Lingor, P., Demleitner, A. F., Wolff, A. W., & Feneberg, E. (2022) · Journal of Neural Transmission · doi:10.1007/s00702-022-02500-w · Cited by 39
Herpesvirus and neurological manifestations in patients with severe coronavirus disease
Carneiro, V. C. D. S., Alves‐Leon, S. V., Sarmento, D. J. D. S., Coelho, W. L. D. C. N. P., Moreira, O. C., Salvio, A. L., Ramos, C. H. F., Filho, C. H. F. R., Marques, C. A. B., Gonçalves, J. P. D. C., et al. (2022) · Virology Journal · doi:10.1186/s12985-022-01828-9 · Cited by 35
“Studies have shown that SARS-CoV-2 can infect cells of the nervous system, even neurons with low expression of angiotensin converting enzyme-2, which plays an important role in viral entry [6, 10, 11].”
Neuro-Axonal Damage and Alteration of Blood–Brain Barrier Integrity in COVID-19 Patients
Zingaropoli, M. A., Iannetta, M., Piermatteo, L., Pasculli, P., Latronico, T., Mazzuti, L., Campogiani, L., Duca, L., Ferraguti, G., Michele, M. D., et al. (2022) · Cells · doi:10.3390/cells11162480 · Cited by 37
Brain organoids: building higher-order complexity and neural circuitry models
Maisumu, G., Willerth, S. M., Nestor, M. W., Waldau, B., Schülke, S., Nardi, F. V., Ahmed, O., Zhou, Y., Durens, M., Liang, B., et al. (2025) · Trends in biotechnology · doi:10.1016/j.tibtech.2025.02.009 · Cited by 47
“For example, brain region-specific organoids, including cortical, hippocampal, hypothalamic, midbrain, and choroid plexus organoids, have demonstrated possible SARS-CoV-2 infection to different extents, and the virus was reported to target neurons, astrocytes, and neurovascular cells [10,107–109].”
Modeling Multi-organ Infection by SARS-CoV-2 Using Stem Cell Technology
Simoneau, C. R., & Ott, M. (2020) · Cell stem cell · doi:10.1016/j.stem.2020.11.012 · Cited by 37
Lai, H. I. A. M., Chou, S., Chien, Y., Tsai, P., Chien, C., Hsu, C., Jheng, Y.-C., Wang, M., Chiou, S., Chou, Y.-B., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031320 · Cited by 34
Human pluripotent stem cell (hPSC) and organoid models of autism: opportunities and limitations
Kilpatrick, S., Irwin, C. L., & Singh, K. K. (2023) · Translational Psychiatry · doi:10.1038/s41398-023-02510-6 · Cited by 36
Jacob, F., Schnoll, J. G., Song, H., & Ming, G. (2021) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/bs.ctdb.2020.12.011 · Cited by 39
Organoids in modelling infectious diseases
Shpichka, A. I., Bikmulina, P., Peshkova, M., Heydari, Z., Kosheleva, N. V., Vosough, M., & Timashev, P. S. (2021) · Drug Discovery Today · doi:10.1016/j.drudis.2021.08.005 · Cited by 37
Advances in 3D culture systems for therapeutic discovery and development in brain cancer
Wanigasekara, J., Cullen, P. J., Bourke, P., Tiwari, B. K., & Curtin, J. F. (2022) · Drug Discovery Today · doi:10.1016/j.drudis.2022.103426 · Cited by 33
Chen, J., Chen, J., Lei, Z., Zhang, F., Zeng, L., Wu, X., Li, S., & Tan, J. (2023) · Translational Psychiatry · doi:10.1038/s41398-023-02692-z · Cited by 34
Pandamooz, S., Jurek, B., Meinung, C.-P., Baharvand, Z., Shahem-abadi, A. S., Haerteis, S., Miyan, J. A., Downing, J. E., Dianatpour, M., Borhani‐Haghighi, A., et al. (2021) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-121120-012309 · Cited by 32
Vavougios, G. D., Nday, C. M., Pelidou, S., Gourgoulianis, K. I., Stamoulis, G. I., Doskas, T. K., & Zarogiannis, S. G. (2021) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2021.100243 · Cited by 35
Unraveling Risk Genes of COVID-19 by Multi-Omics Integrative Analyses
Baranova, A. V., Cao, H., & Zhang, F. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.738687 · Cited by 40
Brain Fog: a Narrative Review of the Most Common Mysterious Cognitive Disorder in COVID-19
Mir, M. A. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03715-y · Cited by 40
Long-COVID: Cognitive deficits (brain fog) and brain lesions in non–hospitalized patients
Hugon, J. (2021) · La Presse Médicale · doi:10.1016/j.lpm.2021.104090 · Cited by 34
“It has been reported in previous studies that SARS-CoV-2 can induce hyperphosphorylation of tau protein or activation of the PKR kinase, two proteins that abnormally accumulate in the brains of Alzheimer's patients [12,13].”
Can SARS-CoV-2 Infection Lead to Neurodegeneration and Parkinson’s Disease?
Krey, L., Huber, M. K., Höglinger, G. U., & Wegner, F. (2021) · Brain Sciences · doi:10.3390/brainsci11121654 · Cited by 32
“The infection induced an altered distribution and hyperphosphorylation of tau and subsequent neuronal death [90].”
BackgroundCellular and Molecular Effects of SARS-CoV-2 Linking Lung Infection to the Brain
Francistiová, L., Klepe, A., Curley, G., Gulya, K., Dinnyés, A., & Filkor, K. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.730088 · Cited by 38
Kettunen, P., Lesnikova, A., Räsänen, N., Ojha, R., Palmunen, L., Laakso, M., Lehtonen, Š., Kuusisto, J., Pietiläinen, O. P. H., Saber, S. H., et al. (2023) · Journal of Virology · doi:10.1128/jvi.00144-23 · Cited by 33
Choroid plexus defects in Down syndrome brain organoids enhance neurotropism of SARS-CoV-2
Shaker, M. R., Slonchak, A., Al-mhanawi, B., Morrison, S. D., Sng, J. D. J., Cooper-White, J. J., Khromykh, A. A., & Wolvetang, E. J. (2024) · Science Advances · doi:10.1126/sciadv.adj4735 · Cited by 35
Stewart, R., Yan, K., Ellis, S. A., Bishop, C. R., Dumenil, T. D., Tang, B., Nguyen, W., Larcher, T., Parry, R. H., Sng, J. D. J., et al. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1320856 · Cited by 35
“As confirmed herein for BA.5 and XBB isolates, human neurons can be readily infected in vitro (Bullen et al., 2020; Ramani et al., 2020; Song et al., 2021; Hou et al., 2022; Mesci et al., 2022; Shen et al., 2022), with infection of neurons also seen in some COVID-19 patients (Song et al., 2021;…”
BackgroundBrain exposure to SARS-CoV-2 virions perturbs synaptic homeostasis
Partiot, E., Hirschler, A., Colomb, S., Lutz, W., Claeys, T., Delalande, F., Deffieu, M. S., Bare, Y., Roels, J. R. E., Gorda, B., et al. (2024) · Nature Microbiology · doi:10.1038/s41564-024-01657-2 · Cited by 35
Sarieva, K., & Mayer, S. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.686410 · Cited by 33
“, 2020), neurons (Jacob et al., 2020;Mesci et al., 2020; Ramani et al., 2020; Song et al., 2020; Zhang et al., 2020; Andrews et al., 2021), and even astrocytes (Jacob et al.”
BackgroundResultDysautonomia and Implications for Anosmia in Long COVID-19 Disease
Vallée, A. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10235514 · Cited by 31
“Moreover, SARSCoV-2 exhibits neuroinvasive capacity in an ACE2-dependent manner to induce neuronal death [57] leading to the initiation of a neurotropism in these patients [62,63].”
BackgroundEnhanced replication of SARS-CoV-2 Omicron BA.2 in human forebrain and midbrain organoids
Hou, Y., Li, C., Yoon, C., Leung, A. O.-W., You, S., Cui, X., Chan, J. F., Pei, D., Cheung, H., & Chu, H. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01241-2 · Cited by 32
The Effects of Extrinsic and Intrinsic Factors on Neurogenesis
Jiang, M. H., Jang, S. E., & Zeng, L. (2023) · Cells · doi:10.3390/cells12091285 · Cited by 36
“Interestingly, SARS-CoV-2 was capable of infecting human neural progenitor cells as well as brain organoids [233], with infected organoids displaying alterations in tau, the hyperphosphorylation of tau at T231, neuronal cell death [234] or the death of nearby cells [235].”
Backgroundde Dios-Figueroa, G. T., Aguilera-Márquez, J. D. R., Camacho-Villegas, T. A., & Lugo-Fabres, P. H. (2021) · Biomedicines · doi:10.3390/biomedicines9060602 · Cited by 35
Covid-19 interface with drug misuse and substance use disorders
Cisneros, I. E., & Cunningham, K. A. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108766 · Cited by 33
“…of multiple inflammatory cytokines and chemokines (IL-1β, IFN-α2, IFN-γ, TNF-α, MCP-1, IL-6, IL-10, IL-12p70, IL-17 A, IL-18, IL-23, IL-33) were generated by SARS-CoV2 exposure of human brain microvascular endothelial cells (hBMVECs), an in vitro model of the BBB (Reynolds and Mahajan, 2021).”
3D Human Organoids: The Next “Viral” Model for the Molecular Basis of Infectious Diseases
Chia, S. P. S., Kong, S. L. Y., Pang, J. K. S., & Soh, B.-S. (2022) · Biomedicines · doi:10.3390/biomedicines10071541 · Cited by 29
“[39] revealed that SARS-CoV-2-infected cortical neurons in human brain organoids showed mislocalisation of the microtubule-associated protein Tau from the axon to the soma, together with phosphorylation at threonine 231 of Tau.”
BackgroundMethodPrimio, C. D., Quaranta, P., Mignanelli, M., Siano, G., Bimbati, M., Scarlatti, A., Piazza, C. R., Spezia, P. G., Perrera, P., Basolo, F., et al. (2023) · PNAS Nexus · doi:10.1093/pnasnexus/pgad282 · Cited by 30
Valyaeva, A. A., Zharikova, A. A., & Sheval, E. V. (2022) · Cell Biology International · doi:10.1002/cbin.11928 · Cited by 32
Dexamethasone attenuates interferon-related cytokine hyperresponsiveness in COVID-19 patients
Engel, J. J., van der Made, C. I., Keur, N., Setiabudiawan, T. P., Röring, R. J., Damoraki, G., Dijkstra, H., Lemmers, H., Ioannou, S., Poulakou, G., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1233318 · Cited by 33
“19 x 10(4) TCID50/ml; NRW-42 isolate, kindly provided by Heiner Schaal, University Hospital Düsseldorf, Germany) (17), heat-inactivated Staphylococcus aureus (1 x 10(6) CFU/mL; clinical isolate), heatinactivated influenza virus H1N1 (3.”
BackgroundInfluentialCao, M., Su, X., & Jiang, S. (2021) · Stem Cell Reports · doi:10.1016/j.stemcr.2020.12.010 · Cited by 27
Zaeck, L. M., Scheibner, D., Sehl‐Ewert, J., Müller, M., Hoffmann, D., Beer, M., Abdelwhab, E. M., Mettenleiter, T. C., Breithaupt, A., & Finke, S. (2021) · Viruses · doi:10.3390/v13030529 · Cited by 30
Shah, D. D., Raghani, N. R., Chorawala, M. R., Singh, S. K., & Prajapati, B. G. (2023) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-023-02541-2 · Cited by 36
Contribution of CNS and extra-CNS infections to neurodegeneration: a narrative review
Kettunen, P., Koıstınaho, J., & Rõlova, T. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03139-y · Cited by 33
The Organoid Platform: Promises and Challenges as Tools in the Fight against COVID-19
Geurts, M. H., van der Vaart, J., Beumer, J., & Clevers, H. C. (2021) · Stem Cell Reports · doi:10.1016/j.stemcr.2020.11.009 · Cited by 27
Neuro-COVID-19: an insidious virus in action
Bratosiewicz‐Wąsik, J. (2021) · Neurologia i Neurochirurgia Polska · doi:10.5603/pjnns.a2021.0072 · Cited by 27
“Moreover, brain organoids could model CNS pathologies of COVID-19 since imaging neurons of organoids exposed to SARS-CoV-2 revealed altered distribution of Tau from axons to soma, hyperphosphorylation, and apparent neuronal death [52].”
BackgroundKujawska, M., Mostafavi, E., & Kaushik, A. K. (2022) · Neural Regeneration Research · doi:10.4103/1673-5374.346486 · Cited by 27
Unraveling Human Brain Development and Evolution Using Organoid Models
Fernandes, S., Klein, D., & Marchetto, M. C. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.737429 · Cited by 30
García‐Escobar, A., Vera, S., y, A. J.-R., Jiménez‐Valero, S., Galeote, G., & Moreno, R. (2022) · Biomolecules · doi:10.3390/biom12010076 · Cited by 27
“The low ACE2 expression in olfactory cells and neuronal cells [83], but with the highest level of ACE2 in olfactory bulbs compared with that in the hippocampi and the brain cortex [63], suggests that the neurotropism of SARS-CoV, to some extent, could be that it depends not only on ACE2, but rather needs other cofacto…”
BackgroundOrganoid Studies in COVID-19 Research
Kim, J., Koo, B., & Clevers, H. C. (2022) · International Journal of Stem Cells · doi:10.15283/ijsc21251 · Cited by 28
Haemorrhage of human foetal cortex associated with SARS-CoV-2 infection
Massimo, M., Barelli, C., Moreno, C., Collesi, C., Holloway, R. K., Crespo, B., Zentilin, L., Williams, A., Miron, V. E., Giacca, M., et al. (2023) · Brain · doi:10.1093/brain/awac372 · Cited by 27
Haverty, R., McCormack, J., Evans, C., Purves, K., O’Reilly, S. R., Gautier, V., Rochfort, K. D., Fabre, A., & Fletcher, N. F. (2024) · Journal of General Virology · doi:10.1099/jgv.0.002009 · Cited by 28
“In contrast, Pellegrini et al. [5] demonstrated that SARS- CoV-2 does not infect neuronal cells within brain organoids, but instead cells of the choroid plexus epithelium, while Ramani et al. [36] demonstrated preferential infection of neurons within brain organoids.”
IFITM proteins promote SARS-CoV-2 infection and are targets for virus inhibitionPreprint
Bozzo, C. P., Nchioua, R., Volčič, M., Krüger, J., Heller, S., Stürzel, C. M., Kmieć, D., Conzelmann, C., Müller, J. A., Zech, F., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.08.18.255935 · Cited by 25
COVID-19 highlights the model dilemma in biomedical research
Adhikary, P. P., Ul Ain, Q., Hocke, A. C., & Hedtrich, S. (2021) · Nature Reviews Materials · doi:10.1038/s41578-021-00305-z · Cited by 25
Varma, P., Lybrand, Z. R., Antopia, M. C., & Hsieh, J. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.614680 · Cited by 24
Susceptibility of neuroblastoma and glioblastoma cell lines to SARS-CoV-2 infection
Bielarz, V., Willemart, K., Avalosse, N., Swert, K. D., Lotfi, R., Lejeune, N., Poulain, F., Ninane, N., Gilloteaux, J., Gillet, N. A., et al. (2021) · Brain Research · doi:10.1016/j.brainres.2021.147344 · Cited by 24
SARS-CoV-2: Pathogenesis, Molecular Targets and Experimental Models
Kanimozhi, G., Bharathiraja, P., Pawar, C. S., Khan, H. A., Alrokayan, S., & Prasad, N. R. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.638334 · Cited by 26
Bhattacharya, A., Choi, W. W. Y., Muffat, J., & Li, Y. (2021) · Journal of Molecular Biology · doi:10.1016/j.jmb.2021.167386 · Cited by 24
COVID ‐19 and neurodegeneration: The mitochondrial connection
Denaro, C. A., Haloush, Y. I., Hsiao, S. Y., Orgera, J. J., Osorio, T., Riggs, L. M., Sassaman, J. W., Williams, S. A., Carlo, A. R. M., da Costa, R. T., et al. (2022) · Aging Cell · doi:10.1111/acel.13727 · Cited by 23
“In a study conducted using 3D human brain organoids, increased presence and redistribution of p- Tau in cortical neurons was found in SARS- CoV- 2 samples compared with the controls (Ramani et al., 2020).”
Liu, J.-F., Peng, W.-J., Wu, Y., Yang, Y.-H., Wu, S., Liu, D., Liu, J., & Yang, J. (2023) · EBioMedicine · doi:10.1016/j.ebiom.2023.104518 · Cited by 25
Zhu, H., Byrnes, C., Lee, Y. T., Tuymetova, G., Duffy, H. B. D., Bakir, J. Y., Pettit, S. N., Angina, J., Springer, D., Allende, M. L., et al. (2023) · The FASEB Journal · doi:10.1096/fj.202300149r · Cited by 26
Bioengineered in Vitro Tissue Models to Study SARS-CoV-2 Pathogenesis and Therapeutic Validation
Chakraborty, J., Banerjee, I., Vaishya, R., & Ghosh, S. (2020) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.0c01226 · Cited by 25
Septyaningtrias, D. E., & Susilowati, R. (2021) · Reviews in the Neurosciences · doi:10.1515/revneuro-2020-0092 · Cited by 24
“Indeed, human brain organoid studies (Mesci et al. 2020; Ramani et al. 2020; Song et al. 2020) and in vivo study in mice overexpressing human ACE2 showed that SARS-CoV2 able to infect neuron (Song et al. 2020; Sun et al. 2020).”
BackgroundWWOX-Related Neurodevelopmental Disorders: Models and Future Perspectives
Steinberg, D. J., & Aqeilan, R. I. (2021) · Cells · doi:10.3390/cells10113082 · Cited by 22
Virus-Induced Membrane Fusion in Neurodegenerative Disorders
Osorio, C. P., Sfera, A., Anton, J. J., Thomas, K. G., Andronescu, C. V., Li, E., Yahia, R., Avalos, A. G., & Kozlakidis, Z. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.845580 · Cited by 23
Liu, Z., Kılıç, G., Li, W., Bulut, O. P., Gupta, M. K., Zhang, B., Qi, C., Peng, H., Tsay, H.-C., Soon, C. F., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.838132 · Cited by 27
“5x105 PBMCs per well were seeded in U-bottom 96-well tissue culture plates (Greiner Bio-One, Austria) and stimulated with 10 ng/ml lipopolysaccharides (LPS) derived from Escherichia coli O55:B5 (Sigma-Aldrich, MO, USA), 106/ml heat-killed Staphylococcus aureus, 106/ml heat-killed Candida albicans, R848 (InvivoGen), or…”
MethodSelf-citationPistollato, F., Petrillo, M., Clerbaux, L., Leoni, G., Ponti, J., Bogni, A., Brogna, C., Cristoni, S., Sanges, R., Gyves, E. M., et al. (2022) · Reproductive Toxicology · doi:10.1016/j.reprotox.2022.04.011 · Cited by 28
Human brain organoids to explore SARS‐CoV‐2‐induced effects on the central nervous system
Ostermann, P. N., & Schaal, H. (2023) · Reviews in Medical Virology · doi:10.1002/rmv.2430 · Cited by 24
“Brain organoids are generated from embryonic or induced pluripotent stem cells (iPSCs).(7,137,139) The possibility to use iPSCs allows the generation of brain organoids from cells (e.”
BackgroundMethodResultInfluentialSelf-citationDelta (B1.617.2) variant of SARS-CoV-2 induces severe neurotropic patterns in K18-hACE2 mice
Yang, J.-H., Yang, M., Kim, D.-M., Kim, B., Tark, D., Kang, S., & Lee, G.-H. (2023) · Scientific Reports · doi:10.1038/s41598-023-29909-x · Cited by 30
Luo, Y., Zhang, M., Chen, Y., Chen, Y., & Zhu, D. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.720099 · Cited by 28
Mukherjee, S., Knop, J., & Winter, R. (2021) · Chemistry - A European Journal · doi:10.1002/chem.202104182 · Cited by 20
Comprehensive Oncogenic Features of Coronavirus Receptors in Glioblastoma Multiforme
Chen, A., Zhao, W., Li, X., Sun, G., Ma, Z., Peng, L., Shi, Z., Li, X., & Yan, J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.840785 · Cited by 23
“Human brain organoids also exhibit the neuroinvasive capability of SARS-CoV-2 (50, 51).”
BackgroundCell and Animal Models for SARS-CoV-2 Research
Bestion, E., Halfon, P., Mezouar, S., & Mège, J. (2022) · Viruses · doi:10.3390/v14071507 · Cited by 26
Direct and indirect impact of SARS-CoV-2 on the brain
Peron, J. P. S. (2023) · Human Genetics · doi:10.1007/s00439-023-02549-x · Cited by 26
Stüdle, C., Nishihara, H., Wischnewski, S., Kulsvehagen, L., Perriot, S., Ishikawa, H., Schroten, H., Frank, S., Deigendesch, N., Pasquier, R. D., et al. (2023) · Fluids and Barriers of the CNS · doi:10.1186/s12987-023-00479-4 · Cited by 26
Could SARS-CoV-2 cause tauopathy?
Pratt, J., Lester, E., & Parker, R. (2021) · The Lancet Neurology · doi:10.1016/s1474-4422(21)00168-x · Cited by 21
The role of autophagy in the pathogenesis of SARS-CoV-2 infection in different cell types
Samimi, N., Farjam, M., Klionsky, D. J., & Rezaei, N. (2021) · Autophagy · doi:10.1080/15548627.2021.1989150 · Cited by 22
Methodologies for Generating Brain Organoids to Model Viral Pathogenesis in the CNS
Hopkins, H. K., Traverse, E. M., & Barr, K. L. (2021) · Pathogens · doi:10.3390/pathogens10111510 · Cited by 23
Metadata
- Authors
- Ramani, A., Müller, L., Ostermann, P. N., Gabriel, E., Abida‐Islam, P., Müller‐Schiffmann, A., Mariappan, A., Goureau, O., Gruell, H., Walker, A., Andrée, M., Hauka, S., Houwaart, T., Dilthey, A., Wohlgemuth, K., Omran, H., Klein, F., Wieczorek, D., Adams, O., Timm, J., Korth, C., Schaal, H., & Gopalakrishnan, J.
- Affiliations
- Düsseldorf University Hospital (DE)
- Centre National de la Recherche Scientifique (FR)
- University of Cologne (DE)
- University Hospital Münster (DE)
- Corresponding author
- Schaal, Heiner
- Gopalakrishnan, Jay
- ORCID
- Ramani, Anand
- Müller, Lisa
- Ostermann, Philipp N
- Gabriel, Elke
- Müller‐Schiffmann, Andreas
- Mariappan, Aruljothi
- Goureau, Olivier
- Gruell, Henning
- Walker, Andreas
- Houwaart, Torsten
- Dilthey, Alexander
- Wohlgemuth, Kai
- Omran, Heymut
- Wieczorek, Dagmar
- Adams, Ortwin
- Timm, Jörg
- Korth, Carsten
- Schaal, Heiner
- Gopalakrishnan, Jay
- Venue
- The EMBO Journal
- Published
- 2020-09-23
- Volume
- 39
- Issue
- 20
- Pages
- e106230-e106230
- ISSN
- 0261-4189 (ISSN-L)
- 1460-2075
- PMC
- PMC7560208
- OpenAlex
- W3081536095
- Cited by
- 518
- References
- 63
- Citations by year
- 2026: 16 · 2025: 39 · 2024: 71 · 2023: 85 · 2022: 126 · 2021: 145 · 2020: 36
- FWCI
- 42.41
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- other-oa
- creativecommons.org/licenses/by-nc-nd/4.0/ (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0/ (vor)
- Locations
- The EMBO Journal (publishedVersion, other-oa)
- bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Kölner Universitäts PublikationsServer (Universität zu Köln) (publishedVersion)
- HAL (submittedVersion, other-oa)
- Funders
- Fritz Thyssen Stiftung (10.17.2.018MN)
- Juergen Manchot Foundation
- Topics
- Health Sciences › Medicine › Clinical Neurology › Long-Term Effects of COVID-19
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Keywords
- SARS-CoV-2, COVID-19 pandemic, brain organoids, neuronal infection, neurotoxicity, tau hyperphosphorylation, neuronal cell death, central nervous system pathology
- MeSH terms
- Betacoronavirus, SARS-CoV-2, Animals, Brain, Chlorocebus aethiops, Humans, Nervous System Diseases, Neurons, Organoids, Vero Cells, tau Proteins, Cell Death
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.